Literature DB >> 2463098

Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen.

T Takeuchi1, C E Rudd, T F Tedder, S F Schlossman, C Morimoto.   

Abstract

The 2H4 antigen, comprised of a 200/220-kDa glycoprotein of the leukocyte common antigen (LCA) family, is expressed on a suppressor inducer, but not a helper inducer subset of T4 cells. Earlier studies have demonstrated that the T4+2H4+ subset of cells maximally responded to the AMLR and this molecule has an important role in generated suppressor signals in AMLR/Con A-activated T cell systems. In the present study, we examined the effect of a series of monoclonal antibodies including anti-2H4 antibody on the initial activation of T4 cells in response to self-Ia antigens. We found that the addition of anti-2H4 antibody resulted in an augmentation of the proliferative response of T4 cells in AMLR, whereas other antibodies reactive with LCA/T200 antigens lacked this ability. Furthermore, anti-2H4 antibody enhanced both IL-2 production and IL-2R expression in this AMLR system. This enhancing effect was inhibited by anti-T3 antibody. Moreover, the suppressor inducer function of AMLR T4 cells was enhanced with anti-2H4 antibody by increasing the number of 2H4+ cells with high antigen density. Taken together, these results suggest that the 2H4 antigen may serve as an accessory structure for enhancing the activation of the T4+2H4+ suppressor inducer subset at initiation of cell triggering.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463098     DOI: 10.1016/0008-8749(89)90358-4

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  CD8+/DR+ T gamma cells inhibit the autologous mixed lymphocyte reaction.

Authors:  M K Haynes; J Miller; L Fuller
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

2.  Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts.

Authors:  Arian Lundberg; Linda S Lindström; J Chuck Harrell; Claudette Falato; Joseph W Carlson; Paul K Wright; Theodoros Foukakis; Charles M Perou; Kamila Czene; Jonas Bergh; Nicholas P Tobin
Journal:  Clin Cancer Res       Date:  2017-09-29       Impact factor: 12.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.